Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2015 | 09-2015 | |
| Sales | 29,806 | 29,151 | 26,981 | 9,685 | 25,331 |
| Cost of Goods | 7,926 | 7,668 | 7,811 | 11,879 | 5,390 |
| Gross Profit | 21,880 | 21,483 | 19,170 | -2,194 | 19,941 |
| Operating Expenses | 23,294 | 21,717 | 21,622 | 36,088 | 20,021 |
| Operating Income | -488 | 434 | -1,641 | -37,403 | 310 |
| Other Income | -1,763 | 356 | 36 | -537 | -1,100 |
| Pre-tax Income | -2,251 | 790 | -1,605 | -37,940 | -790 |
| Income Tax | -198 | 32 | 32 | -303 | -132 |
| Net Income Continuous | -2,053 | 758 | -1,637 | -37,637 | -658 |
| Net Income Discontinuous | 9,811 | N/A | N/A | N/A | N/A |
| Net Income | $7,758 | $758 | $-1,637 | $-37,637 | $-658 |
| EPS Basic Total Ops | 0.22 | 0.02 | -0.05 | -1.09 | -0.02 |
| EPS Basic Continuous Ops | -0.06 | 0.02 | -0.05 | -1.09 | -0.02 |
| EPS Basic Discontinuous Ops | 0.28 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.22 | 0.02 | -0.05 | -1.09 | -0.02 |
| EPS Diluted Continuous Ops | -0.06 | 0.02 | -0.05 | -1.09 | -0.02 |
| EPS Diluted Discontinuous Ops | 0.28 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-315 | $603 | $-1,465 | $-37,218 | $613 |